Clinical trials
Cohort Studies clinical trials
Below are recruiting cohort studies clinical trials, each written for real people, not researchers. We’re tracking 562 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05150249Recruiting
Study of older adults after hip fracture treated in hospitals
This is an observational study that follows people age 65 and older after a hip (femur) fracture to learn about their care and outcomes in participating hospitals. It won’t test a new treatment, but your participation may help improve future care for older patients.
BaggiovaraAges 65 years+ - NCT06676527Recruiting
Vorolanib for advanced kidney cancer after first treatment
This trial tests a targeted therapy pill, vorolanib, for people with advanced kidney cancer that has clear cell features and has gotten worse after initial treatment. It may offer a new option when standard second-line treatments are not working.
Nanjing, JiangsuAges 18–80 - NCT06649058RecruitingPhase 2
Study on combining drugs and radiation for brain metastases
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
Houston, TexasAges 18 years+ - NCT06334705Recruiting
30-year follow-up of the EGEA asthma study
This study invites people who took part in a previous EGEA survey to return for a 30-year check-up. The goal is to track long-term health changes related to asthma and allergies.
GrenobleAges 18 years+ - NCT02839863Recruiting
Breast cancer care follow-up at UMC Utrecht with surveys
This study follows people with breast cancer who receive radiation at UMC Utrecht. It uses routinely collected medical data and questionnaires to better understand outcomes over the long term.
AlmeloAges 18 years+ - NCT07831343Recruiting
Malnutrition in young infants under 6 months study
This study follows infants younger than 6 months who are in the hospital due to acute malnutrition. It aims to better understand their condition and improve care.
Semarang, Central JavaAges 1 day–6 months - NCT05254197Recruiting
Brain tumor monitoring study with follow-up brain scans
This study follows people with lower-grade (WHO grade 2 or less) brain tumors using repeat MRI scans over time. It helps doctors understand how these tumors change and which patients may safely delay treatment at first.
SeoulAges 18 years+ - NCT07211321Recruiting
Diet, inflammation, and muscle loss in older adults
This study looks at how diet and gut health relate to muscle loss (sarcopenia) in adults 60 and older. It aims to understand links between inflammation, gut bacteria, and muscle strength so we can find better ways to prevent frailty.
Lanzhou, GansuAges 60 years+ - NCT06478745Enrolling by invitation
Tracking health in people with multiple conditions
This study follows people aged 60+ with two or more chronic diseases to understand their health journeys and experiences. The goal is to improve care for people with multiple health conditions.
MadridAges 60 years+ - NCT06238401RecruitingPhase 1
Testing ACR246 for advanced solid tumors
This trial tests a new drug called ACR246 for people with advanced solid tumors that have not responded to standard treatments. The study aims to find the safest dose and see if the drug can shrink tumors.
Beijing, Beijing MunicipalityAges 18–75 - NCT06001138Enrolling by invitation
FutureMS-2: A Follow-Up Study for MS
This study follows up with people who have Multiple Sclerosis and were in the earlier FutureMS study. It uses MRI scans to learn more about MS and find better ways to treat it.
AberdeenAges 18 years+ - NCT05266872Recruiting
Earlier diagnosis and better treatment study for Parkinson’s
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
LuxembourgAges 18 years+ - NCT04228211Recruiting
Research study for people newly diagnosed with prostate cancer
This study follows people with newly diagnosed prostate cancer to understand care decisions and outcomes over the long term. It uses routine medical information and asks you to complete questionnaires, which may help improve future treatment and support.
Nieuwegein, UtrechtAges 18 years+ - NCT01206920Recruiting
DC study following HIV prevention and care experiences over time
This study follows people who receive HIV care in Washington, DC and people using HIV prevention medicines (like PrEP) to understand health needs and outcomes over time. It may help improve how HIV care and prevention are delivered in local clinics.
Washington D.C., District of ColumbiaAges Any age - NCT06684327RecruitingPhase 2
Study of three chemotherapy drugs for rare advanced cancers
This trial tests a combination of three chemotherapy drugs (albumin-paclitaxel, ifosfamide, and cisplatin) for people with certain rare cancers that have spread to other parts of the body (stage IV). It looks at how well the treatment works and if it is safe.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07547098Recruiting
Heart, Kidney, and Metabolism Health Long-Term Study
This research study tracks patients with heart disease, kidney disease, or metabolic conditions (like diabetes) over time to understand how these conditions connect and affect long-term health. By collecting medical records and health information, researchers aim to predict outcomes and improve care.
Fuzhou, FujianAges 18–80 - NCT07476703Recruiting
Extended study on the SCAPIS Stockholm reexamined group
This trial studies data and samples from people already taking part in the main SCAPIS reexamination study in Stockholm. It looks for new findings to help understand heart and lung health.
StockholmAges 56–74 - NCT02198976Recruiting
Study for adults with Barrett’s esophagus
This study looks at people age 18+ who have Barrett’s esophagus and checks for early changes that may lead to cancer. You might qualify if you can consent and are not pregnant.
Westmead, New South WalesAges 18–99 - NCT07205861Recruiting
Study of patients with immune TTP in France
This study looks back at medical records of people with immune-mediated thrombotic thrombocytopenic purpura (TTP), a rare blood clotting disorder. It aims to better understand the disease and how it is treated.
ParisAges Any age - NCT07046650RecruitingPhase 2
Cisplatin plus gemcitabine for rare tumors after PD-1 therapy
This trial tests a combination of two chemotherapy drugs, cisplatin and gemcitabine, for people with certain rare cancers that no longer respond to a type of immunotherapy called PD-1 inhibitors. The goal is to see how well this treatment works and what side effects it may cause.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06271291Recruiting
Pancreatic Cancer Detection Study for High-Risk People
This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.
Scottsdale, ArizonaAges 18 years+ - NCT03928509Recruiting
Study of people in Quebec who had COVID-19 in early 2021
This is a study for adults in Quebec who were diagnosed with COVID-19 between November 2020 and May 2021. It aims to learn more about people’s experiences and outcomes after COVID-19, which could help improve future care.
Sherbrooke, QuebecAges Any age - NCT02356497Recruiting
Study of treatments for bone metastases using routine data
This study follows adults with cancer that has spread to the bones and who are receiving radiation treatment. It looks at how interventional (procedure-based) treatment decisions affect outcomes by using information collected during routine care.
Utrecht, UtrechtAges 18 years+ - NCT01574053Recruiting
Global Huntington’s disease registry for gene carriers and controls
This study builds a global record of people who carry the Huntington’s (HD) gene change and people who do not. By comparing them over time, researchers hope to better understand how HD begins and progresses.
Birmingham, AlabamaAges 18 years+
Hear when a new Cohort Studies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cohort studies?
- Yes. Clin2 currently lists 562 recruiting cohort studies studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cohort studies trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cohort studies trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.